AL
ISEE

Airain Ltd’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Airain Ltd’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-37,586
Closed -$138K – 1090
2017
Q1 		$138K Sell
37,586
-532
-1% -$2.25K 0.01% 739
2016
Q4 		$184K Buy
+38,118
New +$1.13M 0.01% 607
2015
Q1 		– Sell
-22,446
Closed -$1.01M – 1001
2014
Q4 		$1.01M Buy
22,446
+10,264
+84% +$431K 0.08% 275
2014
Q3 		$474K Sell
12,182
-10,486
-46% -$412K 0.03% 460
2014
Q2 		$959K Buy
+22,668
New +$832K 0.08% 272

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Airain Ltd's ISEE Position: Q2 2017 in Review

Airain Ltd sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 37,586 shares — an estimated $138K sold.

Airain Ltd first reported a position in ISEE in Q2 2014 and held it in 5 quarters. The position peaked at $1.01M in Q4 2014. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • Airain Ltd reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 37,586 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $138K.
  • Airain Ltd first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • Airain Ltd's IVERIC bio, Inc. Common Stock position peaked at $1.01M in Q4 2014.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.